SCA
BIO icon

Secor Capital Advisors’s Bio-Rad Laboratories Class A BIO Stock Holding History

Secor Capital Advisors’s Portfolio BIO Stock Details BIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		– Sell
-1,561
Closed -$224K – 517
2016
Q2 		$224K Buy
+1,561
New +$223K 0.03% 523
2014
Q4 		– Sell
-1,880
Closed -$213K – 389
2014
Q3 		$213K Buy
+1,880
New +$223K 0.12% 264

Other funds holding BIO

ACM
Atlanta Capital Management Atlanta, Georgia $22.5B AUM 9.67% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AI
Ariel Investments Chicago, Illinois $8.93B AUM 29.58% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CM
Corvex Management New York $2.52B AUM 25.53% 1-Year Est. Return
NIMC
NWQ Investment Management Company Los Angeles, California $2.22B AUM 6.84% 1-Year Est. Return

Secor Capital Advisors's BIO Position: Q3 2016 in Review

Secor Capital Advisors sold out of Bio-Rad Laboratories Class A (BIO) in Q3 2016, closing a stake of 1,561 shares — an estimated $224K sold.

Secor Capital Advisors first reported a position in BIO in Q3 2014 and held it in 2 quarters. The position peaked at $224K in Q2 2016. 241 funds tracked by Wall St. Rank hold BIO as of Q3 2016.

  • Secor Capital Advisors reported no remaining Bio-Rad Laboratories Class A position as of Q3 2016 after selling out during the quarter.
  • Secor Capital Advisors sold 1,561 Bio-Rad Laboratories Class A shares in Q3 2016, an estimated $224K.
  • Secor Capital Advisors first reported a position in Bio-Rad Laboratories Class A in Q3 2014 and held it in 2 quarters.
  • Secor Capital Advisors's Bio-Rad Laboratories Class A position peaked at $224K in Q2 2016.
  • 241 funds tracked by Wall St. Rank held Bio-Rad Laboratories Class A as of Q3 2016.

Based on Secor Capital Advisors's 13F filing for Q3 2016, filed 14 Nov 2016.